ArticleHeart rhythm O22025
Local epicardial robotic-enhanced hybrid ablation efficacy predictors for persistent atrial fibrillation.
Article in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hybrid ablation can manage persistent atrial fibrillation (PsAF) and long-standing persistent atrial fibrillation (LSPAF). Robotic-enhanced hybrid ablation (RE-HA) offers greater precision and stability. However, biophysical predictors of effective local epicardial radiofrequency ablation (ELRF) during epicardial ablation are unknown. Objective: The purpose of this study was to compare the time course of biophysical predictors of ELRF and no-ELRF during the first stage of RE-HA in patients with PsAF and LSPAF. Methods: We conducted a dual-center retrospective cohort study involving 92 consecutive patients with PsAF or LSPAF who underwent RE-HA between January 2021 and May 2024. Epicardial electrogram disappearance, defined as a reduction of bipolar voltages to <0.05 mV, baseline impedance (BI), and impedance drop (ID), were compared between ELRF and no-ELRF cases. Univariate and multivariate logistic regression models were used to identify predictive variables. Optimal cutoff values were determined using receiver operating characteristic curves. Results: Among 2474 radiofrequency (RF) applications, significant predictors of ELRF included BI and ID at 1 and 8 seconds, with optimal cutoff values of <107, 0-7, and 5-17 Ω. The composite predictive model had an area under the receiver operating characteristic of 0.775, with 94% sensitivity, 53% specificity, and 65% accuracy. Our predictive ELRF score ranged from 0-4, and the Youden J test identifying a cutoff value of 3 as optimal. Conclusion: BI and progressive ID were strong predictors of local epicardial RE-HA efficacy. The composite model was a reliable tool for early identification of ELRF, potentially reducing RF delivery and enhancing procedural efficiency. Larger prospective studies are needed to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.